United States: The Number of Vaccines Reduced to 11—A Revolution in Public Health

An expedited procedure that bypasses the usual mechanisms

The process leading up to this major decision was marked by unusual speed and a bypassing of the usual channels for public consultation. Unlike previous changes to the immunization schedule—which were subject to lengthy periods of public consultation, review by the CDC’s Advisory Committee on Immunization Practices (ACIP), and open deliberations involving multiple stakeholders—this reform was implemented without formal public comment or direct involvement from vaccine manufacturers. Deputy Secretary of Health Jim O’Neill, acting as interim director of the CDC, signed the decision memorandum on the same day the changes were announced, January 5, 2026, without the consultation and public debate process traditionally associated with such significant changes to public health policy.

This expedited procedure was justified by the urgency of restoring public trust in health institutions in the face of declining vaccination rates. HHS officials cited a significant decline in public trust in health authorities between 2020 and 2024, accompanied by a drop in routine childhood vaccination rates and an increased risk of vaccine-preventable diseases. According to data cited in the scientific assessment, trust in healthcare institutions plummeted during the COVID-19 pandemic, partly due to controversial policies such as school closures and vaccination mandates in certain regions of the country. Faced with this crisis of confidence, officials deemed it necessary to act quickly to realign the vaccination schedule with what they perceive as an “international consensus” and to strengthen transparency and informed consent.

The speed. That’s what shocks me the most. In just one month—between December 5 and January 5—we went from a presidential memorandum to a complete overhaul of the U.S. vaccination schedule. One month! For decisions that affect millions of children and have potential implications for decades to come. In the scientific world, it takes years to study a single vaccine—to conduct clinical trials, analyze data, publish papers, debate, and consult. And here, everything has been accelerated, compressed, and rushed. I can’t help but think of this passage from the Gospel: “Do unto others as you would have them do unto you.” If these were my own children, I would want certainty, not haste. Verification, not improvisation. Caution, not haste. Yet it is precisely this haste that is being imposed on millions of families. It’s terrifying to realize just how quickly decisions of such magnitude can be made, without the deliberative process that should be the norm for anything related to public health.

Reactions from the International Scientific Community

The announcement of this reform has sparked strong and mixed reactions within the global scientific community. Some experts have hailed this decision as a necessary step toward greater vaccine caution and a recognition of the limits of current knowledge regarding the long-term effects of vaccines administered according to the U.S. schedule. Others have issued stern warnings about the potentially disastrous consequences of this scaling back of universal vaccination recommendations. Michael Osterholm, an epidemiologist at the University of Minnesota and director of the Vaccine Integrity Project, did not mince words in a public statement, calling the decision “radical and dangerous” and emphasizing that it was made without public discussion of the potential impacts on children in the United States or a transparent review of the data on which the changes are based.

Dr. Sean O’Leary, chair of the American Academy of Pediatrics’ Committee on Infectious Diseases, took an even more critical stance, describing the announcement as “the continuation of a decades-long effort by the Secretary of Health to spread fear and falsehoods about vaccines, and it is another step in the Secretary’s effort to dismantle the U.S. vaccination system .” This reaction reflects the deep concern of many pediatricians who fear that this decision marks the beginning of a broader dismantling of public health policies based on scientific evidence. Similarly, Dr. Caitlin Rivers, an epidemiologist and director of the Center for Outbreak Response Innovation at the Johns Hopkins Bloomberg School of Public Health, warned that “a shortened schedule will put children at risk and create the conditions for a resurgence of preventable diseases.”

The divisions within the scientific community astound me. On one side, respected experts who hail this decision as a return to caution. On the other, equally respected authorities who call it dangerous and irresponsible. How can parents navigate this sea of contradictions? For years, we’ve been told that “the science is clear,” that “the experts agree,” that “vaccines are safe and necessary.” Today, experts are publicly at odds, the science seems anything but clear, and vaccines that were indispensable yesterday are now optional. I feel a simmering anger. Why can’t we have certainties? Why is science evolving so rapidly, changing its mind overnight? What I want—what every parent wants—is the truth. Not truths that shift with political administrations, that evolve with trends, that bend to media pressure. A stable, reliable, unshakable truth. But I wonder if that truth even exists anymore in the field of public health.

The Risk of a Resurgence of Preventable Diseases

One of the major concerns raised by this reform is the risk of a resurgence of diseases that had been largely controlled through universal vaccination programs. Epidemiological models suggest that a significant drop in vaccination rates could create conditions conducive to the reappearance of diseases such as bacterial meningitis, hepatitis, or even severe forms of gastroenteritis caused by rotavirus. Historical experience has repeatedly shown that when vaccination rates fall below the critical thresholds necessary for herd immunity, epidemics can emerge rapidly and disproportionately affect the most vulnerable populations, including young children, the elderly, and those with weakened immune systems.

Meningococcal disease is a particularly good illustration of this risk. Although rare, this bacterial infection progresses extremely rapidly, often causing severe symptoms in just a few hours. Without preventive vaccination, mortality rates can reach 10% to 15% even with prompt treatment, and up to 20% of survivors suffer from permanent sequelae such as hearing loss, neurological disorders, or amputations. Similarly, rotavirus, although rarely fatal in developed countries with advanced healthcare systems, remains a major cause of pediatric hospitalization for dehydration, particularly among infants under two years of age. A decline in vaccination rates against these diseases could lead to a significant increase in preventable hospitalizations and deaths, placing an additional burden on an already strained U.S. healthcare system.

I think back to the stories I heard from my grandparents, from a time when meningitis could take a child’s life in a matter of days. These diseases are not ghosts of the past; they are very real threats just waiting for a breach in our defenses to return with a vengeance. And we, in our collective wisdom, have decided to open that breach. It’s as if, after building a solid dike that has protected us for decades, we decided to remove a few stones just to see what happens. The terror that overwhelms me is not so much for myself as for those thousands of children who could become collateral damage in this large-scale social experiment. Parents who choose not to vaccinate their children may do so in good faith, influenced by the new official recommendations. But if, in a few years, we see the return of epidemics we thought we’d banished, who will bear the responsibility? Who will explain to grieving families that their child died because we wanted to conduct a social experiment with public health?

The Consequences for Trust in Health Institutions

Paradoxically, although this reform is presented as a way to restore public trust in health institutions, it could have the opposite effect by reinforcing skepticism toward scientific expertise and official recommendations. By reducing the number of universally recommended vaccines, health authorities seem to be implicitly validating the criticisms of anti-vaccination movements, which have long argued that the U.S. vaccination schedule is too heavy and potentially dangerous. This endorsement, even if unintentional, could encourage more parents to question not only the newly optional vaccines but also those that remain universally recommended, creating a domino effect of mistrust toward the entire vaccination program.

Furthermore, the rushed decision-making process and the bypassing of standard consultation mechanisms have sent the message that public health decisions can be made quickly and arbitrarily under political pressure rather than on the basis of a carefully developed scientific consensus. This perception could further erode public trust in government health agencies and in the scientific methodology itself. Parents who were already hesitant about vaccines might interpret these rapid changes as evidence that previous recommendations were not as firmly grounded in solid evidence as claimed, reinforcing their skepticism toward the entire vaccination program and, more broadly, toward evidence-based medicine.

Trust. That fragile word that shatters so easily and is so difficult to rebuild. In just one month, U.S. health authorities have destroyed decades of hard-earned trust. How can they ever ask parents to trust their expertise after changing course so abruptly? It’s as if your banker, after advising you for years to invest in a specific portfolio, suddenly announced that he had been wrong and that you should sell everything. Would you be inclined to follow his next piece of advice? I certainly wouldn’t. Trust, once broken, leaves scars that never truly fade. Parents will remember this moment—January 5, 2026—when they were told that everything they thought they knew about vaccines could change overnight. That memory, that scar, will shape their relationship with public health forever. And not just for this generation of parents, but for their children as well, who will grow up with the realization that the official truth is not an absolute truth, but a truth subject to change.

A particularly controversial decision in the middle of a busy season

The withdrawal of the universal recommendation for the flu vaccine is perhaps the most controversial aspect of the reform, coming at a time when the United States is experiencing a particularly active flu season. The CDC has reported that nine children have already died from the flu during the 2025–2026 winter season, a statistic that takes on special significance as the agency simultaneously withdraws its recommendation that all children be vaccinated against the virus. The flu remains a major cause of pediatric morbidity and mortality in the United States, resulting in thousands of child hospitalizations each year and inevitable deaths even among healthy children.

The decision to change the status of the flu vaccine from a universal recommendation to a shared clinical decision comes at a time when flu vaccination rates among children were already declining. According to CDC data, only about 50% of American children received the flu vaccine during the 2024–2025 season—a figure already insufficient to ensure adequate protection against the spread of the virus. Infectious disease experts fear that this change in status will further accelerate the decline in vaccination rates, increasing the risk of more severe outbreaks that affect even more children. The situation is particularly concerning given that the flu strains circulating this season appear to be especially virulent, causing higher hospitalization rates than the average over the past five years.

We’re talking about nine children who have died. Nine lives cut short. Nine families devastated. And meanwhile, the CDC announces that the vaccine that might have saved some of these children is no longer a universal priority. It’s a cruel irony that leaves me speechless. I can’t help but think of the parents of these nine children, of their pain, of their despair. If they knew that the very same week they were burying their child, the CDC was withdrawing its recommendation for the vaccine that could have protected him or her, what would they think? What justice is there in this world where cold, bureaucratic decisions made in air-conditioned offices in Washington have such dramatic and deeply personal consequences in hospitals and homes across the country? I feel a deep anger—an anger that cannot be soothed by technical explanations or political justifications. It is a visceral, primal anger—the anger of someone who understands that behind every statistic, every number, every percentage, there are human lives, hopes, and dreams being shattered.

Implications for Epidemiological Surveillance

Alongside changes to vaccination recommendations, U.S. authorities have also announced changes to the mechanisms for monitoring vaccination coverage. On December 30, 2025, the Centers for Medicare & Medicaid Services (CMS) eliminated the requirement for states to report the vaccination status of children enrolled in federal health insurance programs. This decision, made shortly before the announcement of the vaccination schedule reform, has been criticized by public health experts who fear it will reduce the government’s ability to track vaccination trends and quickly identify areas or populations where rates are declining.

More than 40% of American children are covered by Medicaid and the Children’s Health Insurance Program (CHIP), meaning that this reduction in reporting requirements could create a significant blind spot in the national monitoring of vaccination rates. Dr. Michelle Fiscus, a pediatrician and chief medical officer of the Association of Immunization Managers, warned that this decision could create unnecessary doubts about the importance of vaccines and noted that it could contribute to growing fragmentation among states based on their political allegiances. “I think this is going to contribute to this divide among states based on which party is in power,” she said. “We’ll see more of this patchwork of state policies around vaccinations, and that’s unfortunate, because these diseases don’t really care about state lines.”

What terrifies me most about this decision to scale back surveillance is that it seems to be part of a broader pattern of methodically dismantling the structures that protect us. It’s as if we were systematically removing the headlights from a car driving at night on a winding road. Why? Why would we want to stop knowing? Why choose ignorance over knowledge? Vaccination data aren’t abstract numbers; they’re warning signs, early indicators that allow us to act before it’s too late. By reducing our ability to monitor, we’re blinding ourselves to approaching threats. And when we don’t see the threat coming, we can’t prepare; we can’t protect those who rely on us. This abdication of responsibility horrifies me. We are willingly turning a blind eye, choosing not to know rather than facing potentially uncomfortable realities.

Gaps in Understanding Long-Term Effects

A central aspect of the debate surrounding the reform of the vaccination schedule concerns gaps in scientific knowledge regarding the long-term effects of vaccines, particularly when administered according to the U.S. schedule, which recommends multiple, simultaneous doses starting at birth. The authors of the scientific review commissioned by the HHS emphasized the need for more high-quality studies, including placebo-controlled trials and long-term observational studies, to better characterize the benefits, risks, and outcomes of vaccines. This acknowledgment of gaps in current knowledge represents a significant shift from the traditional narrative of public health agencies, which have long presented the vaccination schedule as being based on solid and irrefutable scientific evidence.

The new administration announced that federal health agencies, including the CDC, the FDA, and the National Institutes of Health (NIH), would launch or fund placebo-controlled trials examining the timing of vaccines and their long-term effects. Officials indicated that trials had already begun at the CDC and were being launched at the FDA and the NIH, although they did not provide details on the cost or timeline of these studies. The trials will require follow-up over “many, many years” and will take “quite some time,” officials admitted, meaning that answers to fundamental questions about the long-term safety of vaccines will not be available for years, if not decades.

I’m having a hard time putting into words how I feel about this sudden acknowledgment of the gaps in our understanding of vaccines. For years, we were told that the science was clear, that the studies had been done, that the questions had been resolved. Parents who asked questions about vaccine safety were referred to websites that assured them that everything had been studied, everything had been proven, and everything was safe. And today, we’re essentially being told, “Actually, we don’t really know what the long-term effects are.” This belated revelation fills me with a sense of betrayal. How many times have I had conversations with worried parents, confidently assuring them that the science was sound? How many times have I repeated this mantra, convinced myself of its truth? Today, I wonder if I haven’t unwittingly become an accomplice to a collective delusion. My trust in the scientific system has been shaken, and I don’t know how it can ever be restored.

The Debate on Antigenic Load and Childhood Immunity

An important scientific question underlying the debate over the vaccination schedule concerns the antigenic load resulting from the simultaneous administration of multiple vaccines according to the U.S. schedule. Critics of a dense vaccination schedule argue that exposing an infant to multiple vaccine antigens in a short period of time could potentially overwhelm their developing immune system or cause adverse reactions that would not be observed if the vaccines were administered individually or on a more spaced-out schedule. Although the current scientific consensus suggests that infants’ immune systems are capable of responding to thousands of antigens simultaneously and that the antigenic load of modern vaccines is far lower than that of the natural infections they prevent, this issue remains a subject of intense debate in some communities.

Advocates for reform point out that infants’ immune systems are remarkably robust and evolutionarily adapted to cope with a multitude of antigens from birth. Newborns are exposed to thousands of bacterial and viral antigens in the first hours and days of life through contact with their environment, their mothers, and the world around them. In this context, the additional antigenic load posed by modern vaccines—which contain far fewer antigens than older vaccines thanks to advances in biotechnology—is considered negligible. However, this scientific explanation has failed to convince all parents and some healthcare professionals, who remain concerned about the possibility of cumulative or synergistic effects not detected by current safety studies.

This debate over antigenic load touches me personally. I remember the moment my own child received their first vaccines—those multiple shots in a single visit, that little injection machine that administered several doses simultaneously. I trusted the process; I told myself that if it was recommended by experts, it must be safe. But today, looking back on that moment, I feel a certain unease. Not regret—no—but a question. Why the rush? Why administer so many vaccines at once? Why not space them out, giving each immune response time to establish itself and strengthen? I understand the logistics, the convenience for parents, and the efficiency for the healthcare system. But on an individual level—for that vulnerable child I was caring for—wouldn’t it have been better to take more time? This question that haunts me today helps me understand why so many parents hesitate, why so many parents ask for alternative schedules, and why so many parents don’t trust the official recommendations. It’s not anti-science; it’s parental love.

The Influence of the Trump Administration and Robert F. Kennedy Jr.

The reform of the vaccination schedule cannot be understood without considering its political context and the personal influence of key figures in the Trump administration. Health Secretary Robert F. Kennedy Jr., nephew of former President John F. Kennedy and a controversial figure in American politics, has for decades criticized traditional vaccination policy and raised doubts about vaccine safety. His appointment as head of the HHS by President Trump was seen by many as a signal that the administration would radically reconsider U.S. vaccination policies. Kennedy has long questioned the safety and efficacy of many childhood vaccines and has suggested that vaccination schedules are potentially overloaded and dangerous.

Kennedy’s role in this reform is evident in the HHS’s official statement, which directly quotes his remarks on the need to “align the U.S. childhood vaccination schedule with the international consensus while strengthening transparency and informed consent.” This approach reflects the rhetoric Kennedy has used for years, criticizing what he has called “the vaccine industry” and suggesting that official recommendations were influenced by conflicts of interest rather than based solely on science. However, Kennedy and his supporters assert that this decision is not anti-vaccination, but rather pro-safety, aimed at restoring public trust by acknowledging parents’ legitimate concerns and adopting a more nuanced and personalized approach to childhood vaccination.

Robert F. Kennedy Jr. It is a name that resonates throughout American history, steeped in legend, tragedy, and promise. And today, that name is associated with one of the most heated controversies in public health. I don’t know what to make of this complex figure. On the one hand, I respect his perseverance, his conviction, and his willingness to challenge established certainties. On the other hand, I am concerned to see scientific decisions so deeply influenced by a political figure, whoever that may be. Science should be above politics, impervious to personalities, and shielded from ideologies. But the reality is different. Public health is, by its very nature, a political endeavor. It is politicians who appoint agency directors, vote on budgets, and set priorities. And today, we are seeing the result of this inevitable intertwining of science and politics. I don’t know if this decision is right or wrong, but I do know that it is political. And that’s a problem for me.

Implications for Future Public Health Policy

The reform of the vaccination schedule could have significant implications for the future of public health policy in the United States and potentially in other countries. By radically altering a foundational policy of modern public health, this decision opens the door to further challenges to established principles regarding disease prevention and the protection of public health. Some experts fear that this decision may mark the beginning of an “anti-science” era in public health policy, where recommendations are based on political and popular considerations rather than rigorous scientific evidence.

Conversely, other observers see this reform as a necessary opportunity to rethink the foundations of public health policy and return to an approach that better respects individual autonomy and patient preferences. The central argument of this perspective is that modern public health has too often favored a paternalistic approach, imposing measures through coercion rather than persuasion and education. By restoring trust through transparency and adopting a more personalized approach to vaccination, authorities might finally succeed in increasing vaccination rates—not through coercion, but through conviction. This approach reflects a profound philosophical shift in the conception of the relationship between the state and individuals regarding health, moving from a model of imposed protection to one of shared and informed decision-making.

The future of public health is being decided today. What we are experiencing is not merely a change in vaccination policy; it is a paradigm shift in how we conceive of the relationship between the state and the individual when it comes to health. For decades, the dominant model was that of paternalistic protection: the government knows what’s best for you, the government imposes what’s best for you, and the government even protects you from your own ignorance. This model has likely saved millions of lives, but it has also created resentment, mistrust, and opposition. Today, we are shifting toward a different model: that of informed autonomy. The government provides information; the government offers options; but the individual makes the final decision. Is this better? Is it worse? I don’t know. What I do know is that it’s different. And that this change will not be without pain, without mistakes, without potential tragic consequences. But this is the choice we have made, collectively, and we will have to face the consequences, whatever they may be.

The Perplexity of Foreign Health Authorities

The United States’ decision to drastically scale back its vaccination schedule has sparked reactions of confusion and concern among international health authorities. Many developed countries that use CDC recommendations as a reference have had to address questions from their own citizens about the implications of this decision for their own vaccination policies. The World Health Organization (WHO) has issued cautious statements reminding that vaccination recommendations must be tailored to each country’s specific epidemiological context and that what works in one nation cannot necessarily be directly applied to another without appropriate adjustments.

European countries specifically cited as models by U.S. authorities, such as Denmark and Norway, also reacted with surprise to this decision. Scandinavian public health officials have emphasized that their more limited vaccination schedules do not necessarily mean they consider U.S. vaccines unnecessary, but rather that they are making different choices based on their own assessments of costs, benefits, and public health priorities. As Sean O’Leary, chair of the American Academy of Pediatrics’ Committee on Infectious Diseases, noted, “Many of the decisions they make regarding vaccination schedules are not based on the burden of disease, but rather on cost.” This observation suggests that a direct comparison between U.S. and European schedules could be misleading if it fails to account for these important contextual differences.

I’m thinking of those European countries—Norway, Finland, Denmark—that suddenly find themselves at the forefront of a debate they never asked to be part of. For years, they’ve charted their own course, developing their own policies based on their own assessment of what’s best for their populations. Today, through no choice of their own, they have become models, examples, and evidence in an American debate that is foreign to them. I feel a certain admiration for these countries that have maintained different approaches, that have not simply followed the prevailing consensus, and that have had the courage to think for themselves. But I also feel a certain concern for them, because this sudden attention could create pressures, expectations, and unfair comparisons. What works for a small, homogeneous Scandinavian nation may not necessarily work for a vast and diverse nation like the United States. Yet it is this comparison that is being presented to us as the basis for a major political revolution.

Implications for Developing Countries

While developed countries debate the nuances of their vaccination schedules, the U.S. reform could have particularly significant implications for developing countries. Many low- and middle-income nations rely on CDC and WHO recommendations to develop their own vaccination policies, often lacking the resources and expertise to conduct their own independent assessments. The U.S. decision to scale back its schedule could create confusion among these countries, which might question the necessity of certain vaccines in their own programs, with potentially serious consequences for public health.

In many developing countries, conditions are very different from those in developed nations: access to medical care is limited, health systems are fragile, and the prevalence of certain infectious diseases is much higher. In this context, withdrawing the universal recommendation for vaccines such as those against rotavirus or hepatitis A could have devastating consequences, leading to thousands of additional hospitalizations and deaths among vulnerable children. International health organizations have expressed concern that the U.S. reform could be misinterpreted as justification for scaling back vaccination efforts in developing countries, where vaccines play a crucial role in reducing child mortality.

What concerns me most is the potential domino effect of this decision on countries that cannot afford the luxury of experimentation. When the United States—the richest and most powerful nation in the world—decides to radically change its vaccination policy, the whole world takes note. Developing countries, which are desperately seeking models to follow, might be tempted to follow the American example. But what is a controlled experiment—risky but manageable—in a wealthy healthcare system like that of the United States could become a catastrophe in a country where access to care is limited and the burden of disease is high. I’m thinking of the children in Bangladesh, Nigeria, and Indonesia, who depend on vaccines to survive in conditions we cannot even imagine. This U.S. decision could, indirectly, cost lives in these distant countries. And that thought makes me physically sick.

The Potential Cost of Preventable Epidemics

An often-overlooked aspect of the debate on the vaccination schedule concerns its economic implications. Vaccines, although costly to produce and administer, are widely regarded as one of the most cost-effective public health interventions, preventing billions of dollars in direct medical costs, lost productivity, and human suffering. By reducing the number of universally recommended vaccines, the United States risks significantly increasing the economic costs associated with outbreaks of vaccine-preventable diseases.

The direct costs of an outbreak include hospitalization expenses, medical treatments, doctor visits, and the medications needed to treat patients. But the indirect costs are often much greater: lost productivity among parents who must take time off work to care for sick children, additional childcare costs, the economic impact on businesses when employees are absent, and even the long-term costs for children who suffer permanent complications from a preventable disease. A recent study estimated that every dollar invested in vaccines generates between 10 and 44 dollars in economic return, making it one of the most cost-effective investments in public health.

Health economics is a subject that has always fascinated me, because it forces us to put a price on things that should be priceless: health, life, suffering. I feel uncomfortable with these cold calculations, these equations that tell us a child’s life is worth X dollars, or that an epidemic will cost Y million. Yet these calculations are necessary, because resources are limited and we must make choices. What troubles me about this reform is that it seems to ignore these economic realities. By scaling back universal vaccination, we risk a massive increase in long-term medical costs. The nine children who died from the flu this season represent nine lives irretrievably lost, but they also represent thousands, even millions of dollars in medical costs and economic losses. And this is only the beginning. If vaccination rates continue to fall and outbreaks increase, costs will skyrocket. Was the economy taken into account in this decision? Or did politics take precedence over the economy?

Implications for the Pharmaceutical Industry

The reform of the vaccination schedule could have significant consequences for the U.S. pharmaceutical industry, which invests billions of dollars in the research and development of new vaccines. By removing the universal recommendation for several vaccines, the United States is potentially shrinking the market for these products, which could affect manufacturers’ incentives to invest in vaccine innovation. Vaccines require massive investments in research, lengthy and costly clinical trials, and complex production facilities. Without the guarantee of a large market, these investments could decline, with potentially serious consequences for the future ability to respond to public health emergencies.

However, HHS officials emphasized that all vaccines previously recommended by the CDC will remain covered by insurance without cost-sharing, meaning that families who choose to have their children vaccinated with them will still be able to do so at no cost. Dr. Mehmet Oz, administrator of CMS, stated: “No family will lose access. This framework empowers parents and doctors to make individualized, risk-based decisions, while maintaining strong protection against serious diseases.” This approach aims to balance the reduction in universal recommendations with maintaining access for those who choose to follow a more comprehensive schedule.

The pharmaceutical industry. It’s a phrase that almost immediately provokes strong emotional reactions, whether positive or negative. To some, they are saviors, innovators, miracle-workers. To others, they are predators, profiteers, soulless corporations. The truth, as always, lies somewhere in between. I can’t help but think of the scientists, researchers, and engineers who work at these companies, who spend their days trying to find solutions to complex medical problems. These vaccines that are being removed from universal recommendations didn’t just appear out of thin air. They are the result of decades of work, massive investments, and trial and error. And now, with the stroke of an administrative pen, a significant portion of their market is disappearing. I’m not saying the pharmaceutical industry is perfect—far from it. But if we want it to continue innovating, creating new vaccines, and protecting us against future threats, we must recognize that innovation comes at a cost, and that this cost must be supported by a viable market.

Next Steps in Implementation

Implementing the new U.S. vaccination policy will require complex coordination among federal agencies, state health departments, health care providers, insurers, and families. HHS and the CDC have indicated that they will work with state health agencies, medical groups, and other partners on the next steps and implementation, and that they will educate parents and clinicians on the updated immunization schedules. This education will be crucial to ensuring a clear understanding of exactly what the new “shared clinical decision-making” status means for vaccines that are no longer universally recommended.

Healthcare professionals will need to be trained to have nuanced conversations with parents about the risks and benefits of each vaccine that is now optional, taking into account the specific circumstances of each child and family. This personalized approach represents a significant shift from the previous model, in which healthcare professionals could simply follow the CDC’s universal recommendations. In addition, state health departments will need to decide how to adapt their own school vaccination policies and other mandates in light of this new federal schedule, potentially creating a patchwork of policies across the country.

I’m thinking of primary care physicians, pediatricians, and nurses who are on the front lines. Tomorrow morning, when they walk into their offices, they’ll have to explain to anxious parents why the vaccine they recommended last year is no longer a universal priority. How will they answer the tough questions? How will they manage families’ conflicting expectations? How will they maintain their own professional confidence in the face of these sudden changes? I feel a certain compassion for these professionals who find themselves on the front lines of a revolution they didn’t ask for. Their work was already difficult, balancing science, ethics, and human relationships. Now, an additional layer of political complexity has been added. I fear that some may choose to leave the profession, exhausted by these conflicting pressures. And who will be left to care for our children?

Upcoming Clinical Trials and Their Challenges

As announced by the HHS, placebo-controlled trials will be launched to examine the timing of vaccinations and their long-term effects. These trials will present a major methodological and ethical challenge, as they will require following children over many years to detect any rare or delayed side effects. The design of these studies will need to balance the scientific need to obtain reliable safety data with the ethical consideration of not depriving children of protection against potentially serious diseases.

HHS officials have indicated that the trials would require follow-up over “many, many years” and would take “quite some time,” meaning that answers to fundamental questions about the long-term safety of vaccines will not be available for years, if not decades. In the meantime, parents and healthcare professionals will have to make decisions amid persistent scientific uncertainty. This paradoxical situation—where the reform of the immunization schedule is justified in part by the lack of evidence on long-term safety, yet that evidence will not be available until well after the changes have been implemented—creates a dilemma for all stakeholders.

Waiting. That’s what’s on my mind today. We’re making radical changes right now, saying we need more evidence, but that evidence won’t come for years, perhaps decades. It’s as if we were rebuilding a bridge while it’s still in the air, saying we’ll check the strength of the foundations later. I understand the need to gain a better understanding, to research, to ask questions. But I am terrified by this rush to change before we know. Why not wait for the results of these trials before modifying the universal recommendations? Why reverse the logical order: research first, then change? This decision strikes me as the expression of a society that has lost the ability to wait, to be patient, to tolerate uncertainty. We want answers now, immediate solutions, radical changes. But science doesn’t work that way. The truth requires time, patience, and humility. And these qualities seem sorely lacking in this process.

Issues of Justice and Equity

The reform of the vaccination schedule raises important ethical questions regarding justice and equity in access to protection against infectious diseases. By shifting from a model of universal recommendation to a model of shared clinical decision-making, the United States risks creating inequitable disparities in access to vaccines and, consequently, in protection against diseases. The most educated and well-informed families will likely be better able to navigate this complex new system, understand the risks and benefits of each optional vaccine, and make informed decisions for their children. In contrast, the most vulnerable families—those with less access to information and health care—may not receive the same level of protection.

These potential disparities are particularly concerning given the existing inequalities in the U.S. healthcare system. Minority communities, low-income families, and those living in rural or underserved areas already have lower vaccination rates and more limited access to health care. By removing the universal recommendation for certain vaccines, there is a risk that these disparities will worsen, creating a situation where the most vulnerable children are also the least protected. Proponents of the reform argue that maintaining insurance coverage for all vaccines mitigates this risk, but critics point out that financial access is only one component of equity, and that access to information and high-quality medical advice is just as crucial.

Justice. That word resonates within me like a bell sounding the alarm. What is justice in the realm of health? Is it giving everyone the same thing? Or is it giving everyone what they need—which can be very different? I think of the families I’ve known—those struggling to make ends meet, those who don’t have the time or resources to conduct in-depth research on every vaccine, those who trust official recommendations because they don’t have the luxury of doubt. How will these families navigate this new system of “shared decision-making”? Shared decision-making presupposes two informed parties participating on an equal footing. But when one party has access to all the information, education, and time to reflect, while the other is overwhelmed by the difficulties of daily life, is that truly an equitable division? I fear that this reform will exacerbate existing inequalities, creating a two-tiered society when it comes to health: those who have the resources to protect themselves, and those who do not.

Informed Consent and Parental Autonomy

A central argument in favor of the reform concerns the importance of informed consent and respect for parental autonomy in medical decisions regarding children. Supporters of the new approach argue that parents have the right and responsibility to make informed decisions regarding their children’s health, based on a clear understanding of the risks and benefits of each medical intervention, including vaccines. They contend that the previous model of universal recommendations, while well-intentioned, could sometimes create a dynamic of compliance rather than true informed consent.

However, critics point out that parental autonomy must be balanced against the responsibility to protect children from preventable harm and to protect the community from the spread of infectious diseases. Informed consent, to be genuine, requires a clear and comprehensive understanding of the risks and benefits, which can be difficult to achieve in a field as complex as pediatric immunology. Furthermore, individual decisions regarding vaccination have collective implications, as insufficient vaccination rates can create conditions conducive to the spread of disease, affecting even those who are vaccinated due to the imperfect protection offered by certain vaccines and the presence of vulnerable populations who cannot be vaccinated for medical reasons.

Autonomy. It is a sacred value in our modern society—the right to decide for oneself and for one’s family. I understand this deep attachment to autonomy, this desire not to be dictated to by an external authority, this determination to regain control over the decisions that affect us. But when individual autonomy conflicts with the common good, where do we draw the line? When do my personal decisions begin to threaten the health of my neighbors, my community, and those who cannot protect themselves? I do not claim to have the answer to this complex ethical question. What I feel is a deep ambivalence. On the one hand, I want to respect parents’ right to make decisions for their children. On the other, I want to protect children—all children—from preventable diseases. And I don’t see how to reconcile these two imperatives. It is this tension that torments me, leaves me speechless, and makes me doubt everything I thought I knew.

Lessons to Be Learned from This Reform

The reform of the U.S. vaccination schedule represents a pivotal moment in the history of global public health, the lessons of which will resonate for decades to come. This decision underscores the critical importance of maintaining public trust in health institutions, which is the foundation upon which all effective public health policy rests. The crisis of confidence that prompted this reform did not arise spontaneously; it is the result of a series of decisions and communications that eroded public faith in health authorities, particularly during the COVID-19 pandemic. Rebuilding that trust will require time, transparency, and a genuine commitment to scientific truth, even when it is uncomfortable.

This reform also teaches us that public health cannot be separated from the political and social context in which it operates. Even the most robust scientific recommendations will be of no use if they are perceived as being imposed by a distant authority that is disconnected from the realities and concerns of the public. The future of public health will require a more nuanced and respectful approach, one that combines scientific rigor with empathy, transparency with communication, and technical expertise with community engagement. Vaccines will undoubtedly remain an essential tool for protection against infectious diseases, but the way they are recommended, communicated, and administered will need to evolve to reflect this new reality.

I’m sitting here, in front of my screen, trying to find the words to conclude this text, and I realize that I don’t really know what I think. It’s all so complex, so contradictory, so nuanced. On the one hand, I understand the need for change, the necessity of addressing a legitimate crisis of trust, and the importance of questioning established certainties. On the other hand, I am terrified by the potential consequences—by the risk of a resurgence of diseases we thought we had eradicated, by the prospect of lives that could be lost needlessly. What I do know is that we are at a tipping point. What is happening today in the United States is not just a change in vaccine policy; it is a paradigm shift in our relationship to public health, to scientific authority, and to truth itself. I don’t know if this change is for better or for worse. I don’t know if we will regret this decision or if we will celebrate it as a moment of courage and wisdom. What I do know is that we have crossed a threshold, and there is no turning back. Tomorrow will be different from yesterday. And it is this uncertainty, this opening onto the unknown, that leaves me both horrified and fascinated, as if I were watching a spectacle from which I cannot look away.